267 related articles for article (PubMed ID: 9843011)
1. Topical clindamycin versus systemic tetracycline in the treatment of hidradenitis suppurativa.
Jemec GB; Wendelboe P
J Am Acad Dermatol; 1998 Dec; 39(6):971-4. PubMed ID: 9843011
[TBL] [Abstract][Full Text] [Related]
2. Clindamycin versus clindamycin plus rifampicin in hidradenitis suppurativa treatment: Clinical and ultrasound observations.
Caposiena Caro RD; Cannizzaro MV; Botti E; Di Raimondo C; Di Matteo E; Gaziano R; Bianchi L
J Am Acad Dermatol; 2019 May; 80(5):1314-1321. PubMed ID: 30502416
[TBL] [Abstract][Full Text] [Related]
3. The efficacy and tolerability of tetracyclines and clindamycin plus rifampicin for the treatment of hidradenitis suppurativa: Results of a prospective European cohort study.
van Straalen KR; Tzellos T; Guillem P; Benhadou F; Cuenca-Barrales C; Daxhelet M; Daoud M; Efthymiou O; Giamarellos-Bourboulis EJ; Jemec GBE; Katoulis AC; Koenig A; Lazaridou E; Marzano AV; Matusiak Ł; Molina-Leyva A; Moltrasio C; Pinter A; Potenza C; Romaní J; Saunte DM; Skroza N; Stergianou D; Szepietowski J; Trigoni A; Vilarrasa E; van der Zee HH
J Am Acad Dermatol; 2021 Aug; 85(2):369-378. PubMed ID: 33484766
[TBL] [Abstract][Full Text] [Related]
4. Local wound care and topical management of hidradenitis suppurativa.
Alavi A; Kirsner RS
J Am Acad Dermatol; 2015 Nov; 73(5 Suppl 1):S55-61. PubMed ID: 26470618
[TBL] [Abstract][Full Text] [Related]
5. LAight® Therapy Significantly Enhances Treatment Efficacy of 16 Weeks of Topical Clindamycin Solution in Hurley I and II Hidradenitis Suppurativa: Results from Period A of RELIEVE, a Multicenter Randomized, Controlled Trial.
Schultheis M; Staubach P; Nikolakis G; Grabbe S; Ruckes C; von Stebut E; Kirschner U; Matusiak Ł; Szepietowski JC
Dermatology; 2022; 238(3):476-486. PubMed ID: 34535610
[TBL] [Abstract][Full Text] [Related]
6. Hidradenitis Suppurativa: Rapid Evidence Review.
Wipperman J; Bragg DA; Litzner B
Am Fam Physician; 2019 Nov; 100(9):562-569. PubMed ID: 31674740
[TBL] [Abstract][Full Text] [Related]
7. Lymecycline vs. clindamycin plus rifampicin in hidradenitis suppurativa treatment: clinical and ultrasonography evaluation.
Caposiena Caro RD; Molinelli E; Brisigotti V; Offidani A; Bianchi L
Clin Exp Dermatol; 2021 Jan; 46(1):96-102. PubMed ID: 32683727
[TBL] [Abstract][Full Text] [Related]
8. Clindamycin-Benzoyl Peroxide Gel Compared with Clindamycin Lotion for Hidradenitis Suppurativa: A Randomized Controlled Assessor-Blinded Intra-Patient Pilot Study.
Aarts P; Reeves JL; Ardon CB; van der Zee HH; Prens EP
Dermatology; 2023; 239(4):670-674. PubMed ID: 37080176
[TBL] [Abstract][Full Text] [Related]
9. Clindamycin and rifampicin combination therapy for hidradenitis suppurativa.
Mendonça CO; Griffiths CE
Br J Dermatol; 2006 May; 154(5):977-8. PubMed ID: 16634904
[TBL] [Abstract][Full Text] [Related]
10. The Microbiology of Hidradenitis Suppurativa.
Ring HC; Emtestam L
Dermatol Clin; 2016 Jan; 34(1):29-35. PubMed ID: 26617355
[TBL] [Abstract][Full Text] [Related]
11. Efficacy and safety of topical resorcinol 15% versus topical clindamycin 1% in the management of mild-to-moderate hidradenitis suppurativa: A retrospective study.
Molinelli E; Brisigotti V; Simonetti O; Sapigni C; D'Agostino GM; Rizzetto G; Giacchetti A; Offidani A
Dermatol Ther; 2022 Jun; 35(6):e15439. PubMed ID: 35278025
[TBL] [Abstract][Full Text] [Related]
12. Oral clindamycin and rifampicin in the treatment of hidradenitis suppurativa-acne inversa: can some factors influence the response to the treatment?
Bettoli V; Zauli S; Virgili A
G Ital Dermatol Venereol; 2016 Apr; 151(2):216-8. PubMed ID: 27068603
[No Abstract] [Full Text] [Related]
13. LAight® Therapy Is an Effective Treatment Option to Maintain Long-Term Remission of Hurley I and II Hidradenitis Suppurativa: Results from Period B of RELIEVE, a Multicenter Randomized, Controlled Trial.
Schultheis M; Staubach P; Grabbe S; Ruckes C; von Stebut E; Kirschner U; Matusiak Ł; Szepietowski JC; Nikolakis G
Dermatology; 2022; 238(6):1092-1103. PubMed ID: 35679831
[TBL] [Abstract][Full Text] [Related]
14. Oral clindamycin and rifampicin combination therapy for hidradenitis suppurativa: a prospective study and 1-year follow-up.
Dessinioti C; Zisimou C; Tzanetakou V; Stratigos A; Antoniou C
Clin Exp Dermatol; 2016 Dec; 41(8):852-857. PubMed ID: 27753139
[TBL] [Abstract][Full Text] [Related]
15. Adalimumab versus Rifampicin Plus Clindamycin for the Treatment of Moderate to Severe Hidradenitis Suppurativa: A Retrospective Study.
Marasca C; Annunziata MC; Villani A; Volpe S; Marasca D; Fabbrocini G
J Drugs Dermatol; 2019 May; 18(5):437-438. PubMed ID: 31141853
[TBL] [Abstract][Full Text] [Related]
16. Clindamycin as unique antibiotic choice in Hidradenitis Suppurativa.
Rosi E; Pescitelli L; Ricceri F; Di Cesare A; Novelli A; Pimpinelli N; Prignano F
Dermatol Ther; 2019 Mar; 32(2):e12792. PubMed ID: 30515931
[TBL] [Abstract][Full Text] [Related]
17. Dramatic reduction of clindamycin plasma concentration in hidradenitis suppurativa patients treated with the rifampin-clindamycin combination.
Join-Lambert O; Ribadeau-Dumas F; Jullien V; Kitzis MD; Jais JP; Coignard-Biehler H; Guet-Revillet H; Consigny PH; Delage M; Nassif X; Lortholary O; Nassif A
Eur J Dermatol; 2014; 24(1):94-5. PubMed ID: 24445967
[No Abstract] [Full Text] [Related]
18. Clostridium difficile arising in a patient with hidradenitis suppurativa on clindamycin and rifampin.
Bessaleli E; Scheinfeld N
Dermatol Online J; 2018 May; 24(5):. PubMed ID: 30142743
[TBL] [Abstract][Full Text] [Related]
19. Treatment of rosacea: topical clindamycin versus oral tetracycline.
Wilkin JK; DeWitt S
Int J Dermatol; 1993 Jan; 32(1):65-7. PubMed ID: 8425809
[TBL] [Abstract][Full Text] [Related]
20. Rifampicin and clindamycin for hidradenitis.
Wall D; Kirby B
J Am Acad Dermatol; 2011 Apr; 64(4):790. PubMed ID: 21414503
[No Abstract] [Full Text] [Related]
[Next] [New Search]
